Astec Lifesciences informs about quarterly statement on investor complaints

18 Oct 2016 Evaluate

Astec Lifesciences has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Astec Lifesciences Share Price

704.00 -18.15 (-2.51%)
17-Dec-2025 12:17 View Price Chart
Peers
Company Name CMP
UPL 746.00
PI Industries 3210.00
Bayer CropScience 4388.60
Sharda Cropchem 921.50
Sumitomo Chemical 451.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×